

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * viral transcription (GO:0019083) | 9.33827021 |
| 2 | * translational termination (GO:0006415) | 8.98699752 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 8.93028694 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 8.52552895 |
| 5 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 7.68571401 |
| 6 | * translational elongation (GO:0006414) | 7.68202664 |
| 7 | * cotranslational protein targeting to membrane (GO:0006613) | 7.56250246 |
| 8 | * protein targeting to ER (GO:0045047) | 7.53753745 |
| 9 | maturation of SSU-rRNA (GO:0030490) | 7.25051723 |
| 10 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 7.19725045 |
| 11 | * protein localization to endoplasmic reticulum (GO:0070972) | 7.06144096 |
| 12 | * nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 7.04298283 |
| 13 | * cellular protein complex disassembly (GO:0043624) | 6.98677976 |
| 14 | * viral life cycle (GO:0019058) | 6.97469400 |
| 15 | * translational initiation (GO:0006413) | 6.80560827 |
| 16 | ribosomal large subunit biogenesis (GO:0042273) | 6.16638507 |
| 17 | * protein complex disassembly (GO:0043241) | 6.08980679 |
| 18 | * macromolecular complex disassembly (GO:0032984) | 5.70877440 |
| 19 | * translation (GO:0006412) | 5.12756256 |
| 20 | * nuclear-transcribed mRNA catabolic process (GO:0000956) | 5.05519038 |
| 21 | * protein targeting to membrane (GO:0006612) | 5.00969055 |
| 22 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.91355719 |
| 23 | chaperone-mediated protein transport (GO:0072321) | 4.85896341 |
| 24 | formation of translation preinitiation complex (GO:0001731) | 4.83033708 |
| 25 | * mRNA catabolic process (GO:0006402) | 4.78007897 |
| 26 | respiratory electron transport chain (GO:0022904) | 4.53726165 |
| 27 | phenylpropanoid metabolic process (GO:0009698) | 4.53507379 |
| 28 | * RNA catabolic process (GO:0006401) | 4.46156856 |
| 29 | electron transport chain (GO:0022900) | 4.41858244 |
| 30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.41725226 |
| 31 | flavonoid metabolic process (GO:0009812) | 4.30542691 |
| 32 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.19640820 |
| 33 | rRNA processing (GO:0006364) | 4.01863668 |
| 34 | DNA deamination (GO:0045006) | 4.01741503 |
| 35 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.93691656 |
| 36 | ATP synthesis coupled proton transport (GO:0015986) | 3.93691656 |
| 37 | rRNA metabolic process (GO:0016072) | 3.86117361 |
| 38 | cellular component biogenesis (GO:0044085) | 3.80474652 |
| 39 | protein neddylation (GO:0045116) | 3.70872369 |
| 40 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.68077321 |
| 41 | proteasome assembly (GO:0043248) | 3.60707897 |
| 42 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.54589277 |
| 43 | ATP biosynthetic process (GO:0006754) | 3.51317921 |
| 44 | * protein localization to membrane (GO:0072657) | 3.51270199 |
| 45 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.50469490 |
| 46 | DNA strand elongation (GO:0022616) | 3.49002914 |
| 47 | * establishment of protein localization to membrane (GO:0090150) | 3.41548926 |
| 48 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.41440576 |
| 49 | spliceosomal snRNP assembly (GO:0000387) | 3.37332278 |
| 50 | establishment of integrated proviral latency (GO:0075713) | 3.35956002 |
| 51 | regulation of mitochondrial translation (GO:0070129) | 3.35434716 |
| 52 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.30692108 |
| 53 | termination of RNA polymerase III transcription (GO:0006386) | 3.30692108 |
| 54 | protein complex biogenesis (GO:0070271) | 3.26886236 |
| 55 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.22470208 |
| 56 | DNA replication initiation (GO:0006270) | 3.21343676 |
| 57 | * protein targeting (GO:0006605) | 3.21307660 |
| 58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.18574311 |
| 59 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.17981227 |
| 60 | spliceosomal complex assembly (GO:0000245) | 3.17896688 |
| 61 | * establishment of protein localization to organelle (GO:0072594) | 3.17676759 |
| 62 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.16992188 |
| 63 | negative regulation of ligase activity (GO:0051352) | 3.15629917 |
| 64 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.15629917 |
| 65 | DNA unwinding involved in DNA replication (GO:0006268) | 3.15273016 |
| 66 | telomere maintenance via recombination (GO:0000722) | 3.13837543 |
| 67 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.12593482 |
| 68 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.10755958 |
| 69 | ribosome biogenesis (GO:0042254) | 3.10552898 |
| 70 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.09411426 |
| 71 | protein targeting to mitochondrion (GO:0006626) | 3.07061333 |
| 72 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.03446001 |
| 73 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.03446001 |
| 74 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.99231606 |
| 75 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.99231606 |
| 76 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.99231606 |
| 77 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.98470245 |
| 78 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.97080405 |
| 79 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.97080405 |
| 80 | pseudouridine synthesis (GO:0001522) | 2.96661492 |
| 81 | ribosome assembly (GO:0042255) | 2.95647552 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.95368926 |
| 83 | cellular glucuronidation (GO:0052695) | 2.93278982 |
| 84 | * protein localization to organelle (GO:0033365) | 2.93034505 |
| 85 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.93013767 |
| 86 | UTP biosynthetic process (GO:0006228) | 2.93002439 |
| 87 | mitotic recombination (GO:0006312) | 2.92699890 |
| 88 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.92644412 |
| 89 | GTP biosynthetic process (GO:0006183) | 2.91961224 |
| 90 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.88880086 |
| 91 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.88150624 |
| 92 | establishment of protein localization to mitochondrion (GO:0072655) | 2.88114411 |
| 93 | ncRNA 3-end processing (GO:0043628) | 2.86900910 |
| 94 | termination of RNA polymerase I transcription (GO:0006363) | 2.85605316 |
| 95 | nucleobase biosynthetic process (GO:0046112) | 2.84983752 |
| 96 | mitotic chromosome condensation (GO:0007076) | 2.84698326 |
| 97 | kinetochore organization (GO:0051383) | 2.84553980 |
| 98 | uronic acid metabolic process (GO:0006063) | 2.84294285 |
| 99 | glucuronate metabolic process (GO:0019585) | 2.84294285 |
| 100 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.83593324 |
| 101 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.82968520 |
| 102 | hydrogen ion transmembrane transport (GO:1902600) | 2.82231005 |
| 103 | telomere maintenance via telomere lengthening (GO:0010833) | 2.81905667 |
| 104 | CENP-A containing nucleosome assembly (GO:0034080) | 2.81656797 |
| 105 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.81457860 |
| 106 | rRNA modification (GO:0000154) | 2.80518836 |
| 107 | 7-methylguanosine mRNA capping (GO:0006370) | 2.80244021 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.78548054 |
| 109 | negative regulation of RNA splicing (GO:0033119) | 2.77989793 |
| 110 | DNA replication checkpoint (GO:0000076) | 2.77445188 |
| 111 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.76713646 |
| 112 | transcription from mitochondrial promoter (GO:0006390) | 2.76622817 |
| 113 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.76215700 |
| 114 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.76215700 |
| 115 | NADH dehydrogenase complex assembly (GO:0010257) | 2.76215700 |
| 116 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.75591311 |
| 117 | chromatin remodeling at centromere (GO:0031055) | 2.75540121 |
| 118 | RNA capping (GO:0036260) | 2.75513867 |
| 119 | 7-methylguanosine RNA capping (GO:0009452) | 2.75513867 |
| 120 | ncRNA processing (GO:0034470) | 2.75468969 |
| 121 | protein localization to mitochondrion (GO:0070585) | 2.75091765 |
| 122 | DNA damage response, detection of DNA damage (GO:0042769) | 2.74331491 |
| 123 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.73883889 |
| 124 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.73883889 |
| 125 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.73774319 |
| 126 | oxidative phosphorylation (GO:0006119) | 2.72894859 |
| 127 | establishment of viral latency (GO:0019043) | 2.72578499 |
| 128 | mitotic metaphase plate congression (GO:0007080) | 2.72052096 |
| 129 | transcription from RNA polymerase I promoter (GO:0006360) | 2.70356095 |
| 130 | * gene expression (GO:0010467) | 2.67659590 |
| 131 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.66320161 |
| 132 | * cellular component disassembly (GO:0022411) | 2.64884700 |
| 133 | purine nucleobase biosynthetic process (GO:0009113) | 2.63847760 |
| 134 | protein localization to kinetochore (GO:0034501) | 2.63485228 |
| 135 | positive regulation of ligase activity (GO:0051351) | 2.62179935 |
| 136 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.61928294 |
| 137 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.60833981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.80016926 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.94913536 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.32585721 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.08659402 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.65945448 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.63589859 |
| 7 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.53931457 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.41325944 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.29595273 |
| 10 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.06426477 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.00229277 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.97761692 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.95028891 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.88557316 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.83488362 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.82907035 |
| 17 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.78337045 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.60046268 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.52685018 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.45502342 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.34367241 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.27325776 |
| 23 | * TTF2_22483619_ChIP-Seq_HELA_Human | 2.26874988 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.23163946 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.22684804 |
| 26 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.21715209 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.16283062 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.15179067 |
| 29 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.10855748 |
| 30 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01233044 |
| 31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.95666600 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.94947632 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88347804 |
| 34 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.82313540 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81785425 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74403757 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68973163 |
| 38 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.65563346 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.60727478 |
| 40 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.59367482 |
| 41 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59239765 |
| 42 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.52480110 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52324988 |
| 44 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.52026378 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49635987 |
| 46 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49290496 |
| 47 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.49222234 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47101543 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.46947148 |
| 50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.46620194 |
| 51 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44498784 |
| 52 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.43363021 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39292762 |
| 54 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.38433160 |
| 55 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36620324 |
| 56 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35865870 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35275193 |
| 58 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.32815251 |
| 59 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30119734 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27086848 |
| 61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.26187224 |
| 62 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25018185 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.24212208 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23627078 |
| 65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22579370 |
| 66 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21545937 |
| 67 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20372718 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17317526 |
| 69 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17104894 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16873721 |
| 71 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14237971 |
| 72 | MYC_22102868_ChIP-Seq_BL_Human | 1.13677624 |
| 73 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.13416919 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13264744 |
| 75 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.12895210 |
| 76 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08910464 |
| 77 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07834812 |
| 78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06681744 |
| 79 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.06568075 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06256392 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05943979 |
| 82 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04103260 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02992697 |
| 84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01335031 |
| 85 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.00869853 |
| 86 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.99437430 |
| 87 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99138468 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98518003 |
| 89 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.98078656 |
| 90 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.97178714 |
| 91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96533466 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96335640 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96221721 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95567431 |
| 95 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94746764 |
| 96 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94391300 |
| 97 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94371689 |
| 98 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.94184023 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.93284781 |
| 100 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92038984 |
| 101 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89523771 |
| 102 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89405490 |
| 103 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89347773 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88715304 |
| 105 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87529281 |
| 106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84539605 |
| 107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81917709 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.81550119 |
| 109 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.81187174 |
| 110 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.80621236 |
| 111 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.80487120 |
| 112 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.79384595 |
| 113 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.79217341 |
| 114 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.78896753 |
| 115 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.78621542 |
| 116 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77546687 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76152941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 5.01256412 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.89754559 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 4.07272774 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.12768839 |
| 5 | * MP0003077_abnormal_cell_cycle | 3.07893798 |
| 6 | MP0003111_abnormal_nucleus_morphology | 2.97920707 |
| 7 | MP0008057_abnormal_DNA_replication | 2.79243767 |
| 8 | MP0008932_abnormal_embryonic_tissue | 2.51815373 |
| 9 | MP0008058_abnormal_DNA_repair | 2.29418030 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.26192720 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.21232446 |
| 12 | MP0000566_synostosis | 2.01646417 |
| 13 | MP0003786_premature_aging | 1.83845018 |
| 14 | MP0003123_paternal_imprinting | 1.82723831 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 1.82461099 |
| 16 | MP0000490_abnormal_crypts_of | 1.80668182 |
| 17 | MP0003567_abnormal_fetal_cardiomyocyte | 1.76870606 |
| 18 | MP0000350_abnormal_cell_proliferation | 1.71083825 |
| 19 | MP0001730_embryonic_growth_arrest | 1.69888768 |
| 20 | * MP0002938_white_spotting | 1.62381676 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 1.58477616 |
| 22 | MP0009697_abnormal_copulation | 1.51130887 |
| 23 | MP0003315_abnormal_perineum_morphology | 1.50425958 |
| 24 | MP0002697_abnormal_eye_size | 1.48155024 |
| 25 | MP0003136_yellow_coat_color | 1.47574258 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 1.44845561 |
| 27 | MP0003938_abnormal_ear_development | 1.44384579 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.42855203 |
| 29 | MP0002160_abnormal_reproductive_system | 1.42849627 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.41901124 |
| 31 | MP0006054_spinal_hemorrhage | 1.40849562 |
| 32 | MP0003186_abnormal_redox_activity | 1.38761373 |
| 33 | MP0002132_abnormal_respiratory_system | 1.35463383 |
| 34 | MP0003718_maternal_effect | 1.30972560 |
| 35 | MP0001346_abnormal_lacrimal_gland | 1.28514525 |
| 36 | MP0002019_abnormal_tumor_incidence | 1.25442356 |
| 37 | MP0001529_abnormal_vocalization | 1.24709100 |
| 38 | MP0000858_altered_metastatic_potential | 1.24142374 |
| 39 | MP0003941_abnormal_skin_development | 1.23988348 |
| 40 | MP0003937_abnormal_limbs/digits/tail_de | 1.21880121 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.21708931 |
| 42 | MP0002249_abnormal_larynx_morphology | 1.21382591 |
| 43 | * MP0001697_abnormal_embryo_size | 1.20952350 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.19980370 |
| 45 | * MP0002080_prenatal_lethality | 1.19919511 |
| 46 | * MP0000313_abnormal_cell_death | 1.17694405 |
| 47 | MP0000631_abnormal_neuroendocrine_gland | 1.15884539 |
| 48 | MP0009250_abnormal_appendicular_skeleto | 1.13903304 |
| 49 | MP0001853_heart_inflammation | 1.13704476 |
| 50 | MP0002398_abnormal_bone_marrow | 1.13264448 |
| 51 | MP0000537_abnormal_urethra_morphology | 1.13197366 |
| 52 | MP0005380_embryogenesis_phenotype | 1.11135665 |
| 53 | MP0001672_abnormal_embryogenesis/_devel | 1.11135665 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.10738523 |
| 55 | MP0002722_abnormal_immune_system | 1.10665473 |
| 56 | * MP0001286_abnormal_eye_development | 1.07374255 |
| 57 | MP0002095_abnormal_skin_pigmentation | 1.06838659 |
| 58 | MP0002085_abnormal_embryonic_tissue | 1.06068699 |
| 59 | MP0000750_abnormal_muscle_regeneration | 1.05821843 |
| 60 | MP0003755_abnormal_palate_morphology | 1.05649007 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.03940803 |
| 62 | MP0005499_abnormal_olfactory_system | 1.03940803 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.02994715 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.02994715 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.01082307 |
| 66 | MP0003942_abnormal_urinary_system | 0.99554593 |
| 67 | MP0000689_abnormal_spleen_morphology | 0.98117128 |
| 68 | MP0003984_embryonic_growth_retardation | 0.97278461 |
| 69 | MP0004197_abnormal_fetal_growth/weight/ | 0.97230420 |
| 70 | MP0002429_abnormal_blood_cell | 0.96535425 |
| 71 | MP0002088_abnormal_embryonic_growth/wei | 0.96261736 |
| 72 | MP0005501_abnormal_skin_physiology | 0.96245887 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.94914742 |
| 74 | MP0002282_abnormal_trachea_morphology | 0.94261457 |
| 75 | MP0002210_abnormal_sex_determination | 0.93417838 |
| 76 | MP0002084_abnormal_developmental_patter | 0.92537148 |
| 77 | MP0002092_abnormal_eye_morphology | 0.92012317 |
| 78 | MP0001340_abnormal_eyelid_morphology | 0.91504456 |
| 79 | MP0002086_abnormal_extraembryonic_tissu | 0.91476299 |
| 80 | MP0009785_altered_susceptibility_to | 0.90929289 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 0.90859420 |
| 82 | MP0001293_anophthalmia | 0.90054447 |
| 83 | MP0001800_abnormal_humoral_immune | 0.89755049 |
| 84 | MP0002405_respiratory_system_inflammati | 0.89460026 |
| 85 | MP0005408_hypopigmentation | 0.89000304 |
| 86 | MP0004133_heterotaxia | 0.88728072 |
| 87 | MP0000678_abnormal_parathyroid_gland | 0.88613626 |
| 88 | MP0001905_abnormal_dopamine_level | 0.87461251 |
| 89 | MP0004381_abnormal_hair_follicle | 0.87358147 |
| 90 | MP0006072_abnormal_retinal_apoptosis | 0.87117767 |
| 91 | MP0000716_abnormal_immune_system | 0.87075650 |
| 92 | MP0004142_abnormal_muscle_tone | 0.86642792 |
| 93 | MP0001881_abnormal_mammary_gland | 0.86505705 |
| 94 | MP0009053_abnormal_anal_canal | 0.85889820 |
| 95 | MP0002420_abnormal_adaptive_immunity | 0.85011329 |
| 96 | MP0000685_abnormal_immune_system | 0.84976020 |
| 97 | MP0002163_abnormal_gland_morphology | 0.84898348 |
| 98 | MP0000358_abnormal_cell_content/ | 0.84714034 |
| 99 | MP0001819_abnormal_immune_cell | 0.83413360 |
| 100 | MP0000049_abnormal_middle_ear | 0.83200042 |
| 101 | MP0002006_tumorigenesis | 0.82852458 |
| 102 | MP0005023_abnormal_wound_healing | 0.82325223 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.80676200 |
| 104 | MP0005671_abnormal_response_to | 0.80323823 |
| 105 | MP0002452_abnormal_antigen_presenting | 0.80024567 |
| 106 | MP0002233_abnormal_nose_morphology | 0.79815511 |
| 107 | MP0003890_abnormal_embryonic-extraembry | 0.79608902 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.79021478 |
| 109 | MP0001727_abnormal_embryo_implantation | 0.78858835 |
| 110 | MP0005025_abnormal_response_to | 0.78214688 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.78020934 |
| 112 | MP0005389_reproductive_system_phenotype | 0.77797352 |
| 113 | MP0002102_abnormal_ear_morphology | 0.77769504 |
| 114 | MP0006292_abnormal_olfactory_placode | 0.77232514 |
| 115 | * MP0003861_abnormal_nervous_system | 0.76728676 |
| 116 | MP0002723_abnormal_immune_serum | 0.74966129 |
| 117 | MP0005075_abnormal_melanosome_morpholog | 0.74884910 |
| 118 | MP0005391_vision/eye_phenotype | 0.73993950 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.73604369 |
| 120 | MP0000762_abnormal_tongue_morphology | 0.72781981 |
| 121 | MP0002796_impaired_skin_barrier | 0.72068931 |
| 122 | MP0008877_abnormal_DNA_methylation | 0.71700207 |
| 123 | MP0005000_abnormal_immune_tolerance | 0.71109397 |
| 124 | MP0003121_genomic_imprinting | 0.70918131 |
| 125 | MP0002116_abnormal_craniofacial_bone | 0.70866066 |
| 126 | MP0003448_altered_tumor_morphology | 0.69332277 |
| 127 | MP0002751_abnormal_autonomic_nervous | 0.69277931 |
| 128 | MP0001145_abnormal_male_reproductive | 0.69173333 |
| 129 | MP0003436_decreased_susceptibility_to | 0.66259826 |
| 130 | MP0008789_abnormal_olfactory_epithelium | 0.65921917 |
| 131 | MP0003283_abnormal_digestive_organ | 0.65819916 |
| 132 | MP0010155_abnormal_intestine_physiology | 0.65732684 |
| 133 | MP0002928_abnormal_bile_duct | 0.65696904 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.65360560 |
| 135 | MP0008995_early_reproductive_senescence | 0.64727631 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.64419457 |
| 137 | * MP0002111_abnormal_tail_morphology | 0.64372315 |
| 138 | MP0003011_delayed_dark_adaptation | 0.64059919 |
| 139 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63825922 |
| 140 | MP0002234_abnormal_pharynx_morphology | 0.62636800 |
| 141 | MP0003936_abnormal_reproductive_system | 0.60306679 |
| 142 | MP0000653_abnormal_sex_gland | 0.59184037 |
| 143 | MP0001485_abnormal_pinna_reflex | 0.57966567 |
| 144 | MP0001929_abnormal_gametogenesis | 0.57702630 |
| 145 | MP0000778_abnormal_nervous_system | 0.57606601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 9.09953706 |
| 2 | Reticulocytopenia (HP:0001896) | 8.00153475 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 7.98244278 |
| 4 | Macrocytic anemia (HP:0001972) | 6.08105854 |
| 5 | Pallor (HP:0000980) | 5.58894402 |
| 6 | Colon cancer (HP:0003003) | 3.48126067 |
| 7 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.43569471 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.35839579 |
| 9 | Cerebral edema (HP:0002181) | 3.30071361 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.28497900 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.16746484 |
| 12 | Multiple enchondromatosis (HP:0005701) | 3.15802042 |
| 13 | Thrombocytosis (HP:0001894) | 3.05419666 |
| 14 | Aplastic anemia (HP:0001915) | 3.02628822 |
| 15 | Abnormal hemoglobin (HP:0011902) | 2.99847397 |
| 16 | 11 pairs of ribs (HP:0000878) | 2.96952026 |
| 17 | Oral leukoplakia (HP:0002745) | 2.96082165 |
| 18 | Breast hypoplasia (HP:0003187) | 2.94491611 |
| 19 | Stenosis of the external auditory canal (HP:0000402) | 2.94118847 |
| 20 | Trismus (HP:0000211) | 2.89397095 |
| 21 | Absent thumb (HP:0009777) | 2.89261558 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.88221713 |
| 23 | Birth length less than 3rd percentile (HP:0003561) | 2.83306862 |
| 24 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.79049047 |
| 25 | Lipid accumulation in hepatocytes (HP:0006561) | 2.76660565 |
| 26 | Increased CSF lactate (HP:0002490) | 2.72163072 |
| 27 | Abnormality of reticulocytes (HP:0004312) | 2.71782149 |
| 28 | Exertional dyspnea (HP:0002875) | 2.70912878 |
| 29 | Congenital, generalized hypertrichosis (HP:0004540) | 2.67880666 |
| 30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.64201150 |
| 31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.64201150 |
| 32 | Progressive macrocephaly (HP:0004481) | 2.63905692 |
| 33 | Hepatocellular necrosis (HP:0001404) | 2.63018335 |
| 34 | Depressed nasal ridge (HP:0000457) | 2.62835697 |
| 35 | Abnormality of renal resorption (HP:0011038) | 2.62208780 |
| 36 | Rough bone trabeculation (HP:0100670) | 2.62083036 |
| 37 | Septo-optic dysplasia (HP:0100842) | 2.61309265 |
| 38 | Testicular atrophy (HP:0000029) | 2.57922478 |
| 39 | Carpal bone hypoplasia (HP:0001498) | 2.54199871 |
| 40 | Leukodystrophy (HP:0002415) | 2.54133800 |
| 41 | Hypoplastic pelvis (HP:0008839) | 2.50783186 |
| 42 | Lactic acidosis (HP:0003128) | 2.45318298 |
| 43 | Acute encephalopathy (HP:0006846) | 2.43424311 |
| 44 | 3-Methylglutaconic aciduria (HP:0003535) | 2.38766465 |
| 45 | Renal Fanconi syndrome (HP:0001994) | 2.37022349 |
| 46 | Selective tooth agenesis (HP:0001592) | 2.34289713 |
| 47 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.33818678 |
| 48 | Respiratory difficulties (HP:0002880) | 2.32665154 |
| 49 | Glossoptosis (HP:0000162) | 2.32340807 |
| 50 | Hypoplasia of the radius (HP:0002984) | 2.26954621 |
| 51 | Patellar aplasia (HP:0006443) | 2.21582812 |
| 52 | Rib fusion (HP:0000902) | 2.21086878 |
| 53 | Hepatic necrosis (HP:0002605) | 2.20672730 |
| 54 | Triphalangeal thumb (HP:0001199) | 2.15422105 |
| 55 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.13716738 |
| 56 | Thick lower lip vermilion (HP:0000179) | 2.12601136 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.12512250 |
| 58 | Reduced antithrombin III activity (HP:0001976) | 2.12076838 |
| 59 | Microretrognathia (HP:0000308) | 2.07905057 |
| 60 | Increased serum lactate (HP:0002151) | 2.06570729 |
| 61 | Premature graying of hair (HP:0002216) | 2.05242984 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.04788377 |
| 63 | Migraine (HP:0002076) | 2.04581778 |
| 64 | Atresia of the external auditory canal (HP:0000413) | 2.04058168 |
| 65 | Exercise intolerance (HP:0003546) | 2.03997329 |
| 66 | Abnormality of methionine metabolism (HP:0010901) | 2.02975096 |
| 67 | Megaloblastic anemia (HP:0001889) | 2.01891855 |
| 68 | Cleft eyelid (HP:0000625) | 2.01878831 |
| 69 | Absent septum pellucidum (HP:0001331) | 2.00454617 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 1.98444469 |
| 71 | Glycosuria (HP:0003076) | 1.98444469 |
| 72 | IgM deficiency (HP:0002850) | 1.97858573 |
| 73 | Partial duplication of the phalanx of hand (HP:0009999) | 1.96727090 |
| 74 | Hyperphosphaturia (HP:0003109) | 1.96390310 |
| 75 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95815289 |
| 76 | Asplenia (HP:0001746) | 1.95570080 |
| 77 | Optic disc pallor (HP:0000543) | 1.94800424 |
| 78 | Abnormal trabecular bone morphology (HP:0100671) | 1.93879204 |
| 79 | Partial duplication of thumb phalanx (HP:0009944) | 1.93443461 |
| 80 | Neoplasm of the pancreas (HP:0002894) | 1.92335733 |
| 81 | Nasolacrimal duct obstruction (HP:0000579) | 1.91878082 |
| 82 | Abnormality of the septum pellucidum (HP:0007375) | 1.90235188 |
| 83 | Missing ribs (HP:0000921) | 1.90018511 |
| 84 | Abnormal number of incisors (HP:0011064) | 1.88752136 |
| 85 | Type I transferrin isoform profile (HP:0003642) | 1.88703350 |
| 86 | Horseshoe kidney (HP:0000085) | 1.87261541 |
| 87 | Sparse eyelashes (HP:0000653) | 1.87032061 |
| 88 | Respiratory failure (HP:0002878) | 1.86902332 |
| 89 | Degeneration of anterior horn cells (HP:0002398) | 1.83746182 |
| 90 | Abnormality of the anterior horn cell (HP:0006802) | 1.83746182 |
| 91 | Absent radius (HP:0003974) | 1.83471698 |
| 92 | Gout (HP:0001997) | 1.83174117 |
| 93 | Cerebral hypomyelination (HP:0006808) | 1.82046280 |
| 94 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.80152027 |
| 95 | Myelodysplasia (HP:0002863) | 1.78416108 |
| 96 | Patent foramen ovale (HP:0001655) | 1.78312252 |
| 97 | Woolly hair (HP:0002224) | 1.77975531 |
| 98 | Cellular immunodeficiency (HP:0005374) | 1.77111948 |
| 99 | Myokymia (HP:0002411) | 1.76497940 |
| 100 | Concave nail (HP:0001598) | 1.75736837 |
| 101 | Secondary amenorrhea (HP:0000869) | 1.75029556 |
| 102 | Abnormality of the parietal bone (HP:0002696) | 1.74637268 |
| 103 | Abnormality of the preputium (HP:0100587) | 1.73009972 |
| 104 | Hyperthyroidism (HP:0000836) | 1.71697012 |
| 105 | Forearm undergrowth (HP:0009821) | 1.68394608 |
| 106 | Absent forearm bone (HP:0003953) | 1.68272163 |
| 107 | Aplasia involving forearm bones (HP:0009822) | 1.68272163 |
| 108 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.68119859 |
| 109 | Abnormal urine phosphate concentration (HP:0012599) | 1.68016367 |
| 110 | Meckel diverticulum (HP:0002245) | 1.67742212 |
| 111 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.67274580 |
| 112 | Maternal diabetes (HP:0009800) | 1.66991447 |
| 113 | Pancytopenia (HP:0001876) | 1.66402228 |
| 114 | Lethargy (HP:0001254) | 1.66161435 |
| 115 | Homocystinuria (HP:0002156) | 1.64294747 |
| 116 | Abnormality of homocysteine metabolism (HP:0010919) | 1.64294747 |
| 117 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.63791449 |
| 118 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.63791449 |
| 119 | Single umbilical artery (HP:0001195) | 1.63791449 |
| 120 | Abnormality of the ileum (HP:0001549) | 1.63597759 |
| 121 | Abnormal lung lobation (HP:0002101) | 1.61926891 |
| 122 | Renal tubular dysfunction (HP:0000124) | 1.61275203 |
| 123 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.59728122 |
| 124 | Muscle fiber atrophy (HP:0100295) | 1.59524251 |
| 125 | Increased muscle lipid content (HP:0009058) | 1.59281302 |
| 126 | Abnormality of secondary sexual hair (HP:0009888) | 1.58698890 |
| 127 | Abnormality of the axillary hair (HP:0100134) | 1.58698890 |
| 128 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.58586987 |
| 129 | Premature ovarian failure (HP:0008209) | 1.58418423 |
| 130 | Petechiae (HP:0000967) | 1.58121479 |
| 131 | Sparse lateral eyebrow (HP:0005338) | 1.57572770 |
| 132 | Abnormality of the lacrimal duct (HP:0011481) | 1.57164958 |
| 133 | Abnormality of the umbilical cord (HP:0010881) | 1.56691500 |
| 134 | Poor head control (HP:0002421) | 1.56200093 |
| 135 | X-linked dominant inheritance (HP:0001423) | 1.55277367 |
| 136 | Abnormality of placental membranes (HP:0011409) | 1.54323024 |
| 137 | Amniotic constriction ring (HP:0009775) | 1.54323024 |
| 138 | Abnormality of cochlea (HP:0000375) | 1.54084839 |
| 139 | Decreased subcutaneous fat (HP:0001002) | 1.53664445 |
| 140 | Short nose (HP:0003196) | 1.50479015 |
| 141 | Hypoplasia of the ulna (HP:0003022) | 1.50254265 |
| 142 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.50138828 |
| 143 | Increased serum pyruvate (HP:0003542) | 1.49528741 |
| 144 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.49451700 |
| 145 | Median cleft lip (HP:0000161) | 1.48999324 |
| 146 | Neoplasm of head and neck (HP:0012288) | 1.47271058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.76675896 |
| 2 | VRK2 | 4.44671382 |
| 3 | BUB1 | 4.00442644 |
| 4 | WEE1 | 3.74089879 |
| 5 | ARAF | 2.72884797 |
| 6 | STK16 | 2.70809799 |
| 7 | SRPK1 | 2.56855473 |
| 8 | RPS6KB2 | 2.44678898 |
| 9 | EIF2AK1 | 2.43009356 |
| 10 | CDC7 | 2.26234950 |
| 11 | TLK1 | 2.21237339 |
| 12 | VRK1 | 2.20156354 |
| 13 | LRRK2 | 2.13186933 |
| 14 | PIM2 | 2.10420710 |
| 15 | MAP3K12 | 2.04756750 |
| 16 | MST4 | 2.00701464 |
| 17 | TGFBR1 | 1.79808954 |
| 18 | EIF2AK3 | 1.77129438 |
| 19 | DYRK3 | 1.76952274 |
| 20 | PASK | 1.75911853 |
| 21 | RPS6KA4 | 1.74821247 |
| 22 | BRSK2 | 1.70052495 |
| 23 | MKNK1 | 1.67025270 |
| 24 | TESK2 | 1.61626837 |
| 25 | AURKB | 1.53445163 |
| 26 | NEK2 | 1.50136020 |
| 27 | NME1 | 1.49992353 |
| 28 | CDK7 | 1.43227265 |
| 29 | TAF1 | 1.42438935 |
| 30 | TSSK6 | 1.40377417 |
| 31 | EEF2K | 1.37394347 |
| 32 | PLK4 | 1.33057010 |
| 33 | ILK | 1.32528672 |
| 34 | EPHA2 | 1.30616198 |
| 35 | PLK1 | 1.29971518 |
| 36 | ACVR1B | 1.28085784 |
| 37 | MAP4K1 | 1.17415381 |
| 38 | KDR | 1.17090128 |
| 39 | BMPR1B | 1.10993691 |
| 40 | MAPK15 | 1.09618089 |
| 41 | PBK | 1.06256654 |
| 42 | PAK4 | 1.05722124 |
| 43 | AURKA | 1.03754390 |
| 44 | PNCK | 1.01582298 |
| 45 | MAP3K8 | 1.00355660 |
| 46 | TTK | 0.99668002 |
| 47 | STK10 | 0.99065987 |
| 48 | PIM1 | 0.95264805 |
| 49 | ATR | 0.92695056 |
| 50 | CSNK2A2 | 0.89546780 |
| 51 | MKNK2 | 0.87065327 |
| 52 | CDK19 | 0.85155357 |
| 53 | RPS6KA5 | 0.83536959 |
| 54 | PLK3 | 0.83273730 |
| 55 | CDK4 | 0.82043055 |
| 56 | MAP3K3 | 0.81345943 |
| 57 | CSNK1E | 0.81326711 |
| 58 | CSNK2A1 | 0.80567092 |
| 59 | TESK1 | 0.79523117 |
| 60 | PAK1 | 0.77668963 |
| 61 | BTK | 0.77360226 |
| 62 | LIMK1 | 0.77091958 |
| 63 | NEK1 | 0.77090014 |
| 64 | TEC | 0.76899678 |
| 65 | MAP2K3 | 0.76790970 |
| 66 | FLT3 | 0.75453431 |
| 67 | CDK9 | 0.74594574 |
| 68 | STK4 | 0.74051012 |
| 69 | SMG1 | 0.73806482 |
| 70 | LATS2 | 0.73289821 |
| 71 | CHEK2 | 0.73022960 |
| 72 | DYRK2 | 0.72530017 |
| 73 | BRSK1 | 0.69126555 |
| 74 | NUAK1 | 0.67785925 |
| 75 | BLK | 0.67658401 |
| 76 | MAPKAPK3 | 0.67555940 |
| 77 | EIF2AK2 | 0.67390738 |
| 78 | MAP3K11 | 0.67017159 |
| 79 | CHEK1 | 0.66908349 |
| 80 | CDK8 | 0.61828483 |
| 81 | IKBKB | 0.61243429 |
| 82 | AKT2 | 0.60753148 |
| 83 | ZAP70 | 0.59001746 |
| 84 | ABL2 | 0.57938559 |
| 85 | SCYL2 | 0.53830903 |
| 86 | MAP3K9 | 0.53715538 |
| 87 | MAP3K10 | 0.53568821 |
| 88 | PAK2 | 0.53501116 |
| 89 | ZAK | 0.52588780 |
| 90 | PRKCI | 0.52053246 |
| 91 | STK24 | 0.51396608 |
| 92 | GRK6 | 0.51156265 |
| 93 | CDK1 | 0.50730836 |
| 94 | MYLK | 0.50016043 |
| 95 | MAP2K2 | 0.48802644 |
| 96 | PDK2 | 0.47887683 |
| 97 | KIT | 0.47809634 |
| 98 | NLK | 0.45661680 |
| 99 | CDK3 | 0.45523489 |
| 100 | CCNB1 | 0.44578280 |
| 101 | TYK2 | 0.44349984 |
| 102 | CDK11A | 0.44246094 |
| 103 | CDK2 | 0.43434979 |
| 104 | DMPK | 0.42789659 |
| 105 | ATM | 0.41933542 |
| 106 | DAPK3 | 0.41546589 |
| 107 | CLK1 | 0.41401002 |
| 108 | CDK6 | 0.40866877 |
| 109 | LYN | 0.38240187 |
| 110 | PKN2 | 0.38191622 |
| 111 | EPHB2 | 0.37584785 |
| 112 | MAPKAPK2 | 0.33557624 |
| 113 | BRAF | 0.33319380 |
| 114 | RPS6KL1 | 0.33073968 |
| 115 | RPS6KC1 | 0.33073968 |
| 116 | ERBB4 | 0.32793198 |
| 117 | PRKDC | 0.32395708 |
| 118 | RPS6KA6 | 0.31806103 |
| 119 | TXK | 0.31426176 |
| 120 | DYRK1B | 0.31084346 |
| 121 | UHMK1 | 0.29962906 |
| 122 | BCKDK | 0.29825089 |
| 123 | WNK4 | 0.29775413 |
| 124 | RPS6KA1 | 0.29648845 |
| 125 | MELK | 0.28655921 |
| 126 | LCK | 0.28468730 |
| 127 | SYK | 0.28408231 |
| 128 | PRKACB | 0.27055667 |
| 129 | PTK6 | 0.25421049 |
| 130 | CDK15 | 0.23231492 |
| 131 | MAPK14 | 0.22546490 |
| 132 | TNIK | 0.22544310 |
| 133 | ICK | 0.20436329 |
| 134 | CDK14 | 0.19752371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Ribosome_Homo sapiens_hsa03010 | 7.38919436 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.92389100 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.71639764 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.50518576 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.12645786 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 3.09187246 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.79534769 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.45948693 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.42451059 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.39357551 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39248943 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.38699839 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.33902884 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.32604949 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28728256 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.14214988 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.91753904 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.86940937 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.67043400 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.63801845 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.54307134 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.54244311 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.52821303 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.51988216 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50721336 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.47991960 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46925135 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40614702 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.34478002 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32100397 |
| 31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20974022 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.15288624 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14502376 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.08375893 |
| 35 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.08357470 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01849602 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.96545834 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95616826 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91875223 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88421599 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87235856 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84321754 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77998855 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.75963489 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74738462 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74147188 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71920625 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66399893 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64128678 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.63770533 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60557576 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60218595 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59361993 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56721515 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56291700 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55518816 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.54877677 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52589576 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50121169 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50015087 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.48594322 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.47774840 |
| 63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47367480 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46562996 |
| 65 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46138975 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44622125 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43762283 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43252229 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42992202 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42811990 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40053881 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40039125 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39881488 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.39757536 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.38022940 |
| 76 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36605060 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34374092 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.34255959 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.33451193 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33188070 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33178829 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32817426 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32656059 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30439152 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30026525 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.29335525 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.28131714 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27923454 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27694056 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26901515 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26878383 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.26311161 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26233936 |
| 94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25718371 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.25531130 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.23672109 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22431390 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.22142457 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.21835640 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21790172 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21175014 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21058043 |
| 103 | Pathways in cancer_Homo sapiens_hsa05200 | 0.20985700 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20211984 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.20092754 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.19314984 |
| 107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.17928613 |
| 108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.17375371 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16723584 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15162906 |
| 111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.14949351 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.14728890 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.13624743 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13301936 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.13230322 |
| 116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.12842303 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12173957 |
| 118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.11814463 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11052032 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11044783 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.10257005 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.10168237 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.09811628 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.09567466 |
| 125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.09540743 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.09348909 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.06753680 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.01460830 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | -0.0768479 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0624315 |
| 131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | -0.0387364 |
| 132 | Caffeine metabolism_Homo sapiens_hsa00232 | -0.0383445 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0132242 |
| 134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | -0.0108443 |
| 135 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | -0.0008831 |

